Cassava Sciences, Inc. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $115 M for Cassava Sciences, Inc., 4.5 times as much (market caps of Aug 1, 2026 for Cassava Sciences, Inc. and Oct 6, 2026 for Regenxbio Inc.). Cassava Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- Both made a net loss: $76 M for Cassava Sciences, Inc. and $194 M for Regenxbio Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Cassava Sciences, Inc. SAVA · #18,221 in the world | Regenxbio Inc. RGNX · #12,415 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 1998 | — |
| Size | ||
| Market cap | $115 M | $513 M |
| Revenue | $0 M | $170 M |
| Net income | $-76 M▲ best | $-194 M |
| Employees | — | 372 |
| Valuation | ||
| Price to sales | — | 3.3× |
| Price to book | 0.5× | 5.0× |
| Free cash flow yield | — | -24.6% |
| Profitability | ||
| Operating margin | — | -94.6% |
| Net margin | — | -113.8% |
| Return on equity | — | -107.0% |
| Growth | ||
| Revenue growth | — | 104.5% |
| Revenue growth, 3 years a year | — | 14.8% |
| Cash | ||
| Free cash flow margin | — | -74.1% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Aug 2026 | Market cap Oct 2026; ratios FY2025 |
Questions and answers#
Which is bigger, Cassava Sciences, Inc. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $115 M for Cassava Sciences, Inc., 4.5 times as much (market caps of Aug 1, 2026 for Cassava Sciences, Inc. and Oct 6, 2026 for Regenxbio Inc.). Cassava Sciences, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, Cassava Sciences, Inc. or Regenxbio Inc.?
Both made a net loss: $76 M for Cassava Sciences, Inc. and $194 M for Regenxbio Inc.